Prostate cancer raises risk of Alzheimer’s

Blitz BUREAU NEW DELHI: Standard hormone therapy treatment used for prostate cancer may be adversely raising the risk of Alzheimer’s disease in men with the cancer, according to a study on August 29. Androgen deprivation therapy (ADT) is used to treat prostate cancer. It reduces testosterone (the most common androgen), which the cancer needs to…